Phase II Testing. Except as set forth in Section 5.11.1, by the end of Collaboration Year 11, Monsanto shall in good faith initiate Phase II Testing, [* * *] (a) [* * *] (b) [* * *] (c) [* * *] *** Confidential treatment has been requested for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission. (d) [* * *] (e) [* * *] (f) [* * *] (g) [* * *] (h) [* * *] (i) [* * *]
Appears in 2 contracts
Sources: Collaboration Agreement (Evogene Ltd.), Collaboration Agreement (Evogene Ltd.)
Phase II Testing. Except as set forth in Section 5.11.1, by the end of Collaboration Year 11, Monsanto shall in good faith initiate Phase II Testing, [* * *]
(a) [* * *].
(b) [* * *].
(c) [* * *] ]. *** Confidential treatment has been requested for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission.
(d) [* * *].
(e) [* * *].
(f) [* * *].
(g) [* * *].
(h) [* * *].
(i) [* * *].
Appears in 1 contract